Previous 10 | Next 10 |
Horizon Therapeutics is a biotechnology company focused on capital efficiency and commercialization. The company has built a strong track record acquiring assets early and then efficiently bringing them to market. This has led to their business model increasingly resembling Danahe...
-- Key presentations feature investigational programs in rheumatoid arthritis and data evaluating KRYSTEXXA ® (pegloticase injection) for people with uncontrolled gout who received a kidney transplant -- Horizon Therapeutics plc (Nasdaq: HZNP) today announced data p...
Horizon Therapeutics plc (Nasdaq: HZNP) today announced that it has been named to the Great Place to Work ® Best Workplaces in Chicago 2021 list , ranking No. 13 in the large company category. The list includes 39 other top large sized companies, as well as 50 best small-to...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips The biotech sector is synonymous with innovation in a sense. The scientific advancement required to produce the next breakthrough therapeutic drug or device is inherently innovative. There are multiple ways to understand ...
Horizon Therapeutics plc (Nasdaq: HZNP) today announced that it ranked #1 in overall corporate reputation among U.S. patient groups that reported working with the company, and #2 in overall corporate reputation among U.S. patient groups familiar with the company. These results are based...
Improving macroeconomic metrics have lately triggered a stock market slump because investors expect the Fed to tighten its monetary policy. However, projected GDP growth and rising consumer spending should help the market rebound soon. Therefore, we think it wise to buy Salesforce.com (CRM), ...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips During the past year, there was a justifiable obsession with the race to a vaccine for the novel coronavirus. And the companies in that race were making headlines constantly, with prices for longshots soaring and even the b...
Horizon Therapeutics plc (Nasdaq: HZNP) today announced that the Company will participate in the following conference in May: Bank of America Securities 2021 Health Care Conference (Virtual) Date: Tuesday, May 11, 2021 Presentation Time: 3:30 p.m. ET The conf...
-- Separate analysis published in the Annals of Neurology assesses a potential new biomarker for NMOSD attack risk, severity and treatment effects -- Horizon Therapeutics plc (Nasdaq: HZNP) today announced the publication of a new analysis of the pivotal Phase 2/3 N-...
Horizon Therapeutics plc (Nasdaq: HZNP) today announced that Elizabeth H.Z. Thompson, Ph.D., executive vice president, research and development, has been named a 2021 Healthcare Businesswomen’s Association (HBA) Luminary. Dr. Thompson will be honored at the 2021 HBA Woman of the ...
News, Short Squeeze, Breakout and More Instantly...
Horizon Therapeutics Public Limited Company Company Name:
HZNP Stock Symbol:
NASDAQ Market:
Hitachi Construction Machinery Co. Ltd ADR (HTCMY) is expected to report for Q2 2024 DigitalBridge Group Inc. (DBRG) is expected to report $0 for Q3 2023 LY Corp ADR (YAHOY) is expected to report for Q2 2024 DT Midstream Inc. (DTM) is expected to report $0.9 for Q3 2023 Summit Mat...
Horizon Therapeutics Public Limited Company (HZNP) is expected to report $1.22 for Q3 2023
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION FOR IMMEDIATE RELEASE October 6, 2023 RECOM...